These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9927304)
21. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991 [TBL] [Abstract][Full Text] [Related]
22. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. Ahmad F; Goldstein BJ J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760 [TBL] [Abstract][Full Text] [Related]
23. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409 [TBL] [Abstract][Full Text] [Related]
24. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression. Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805 [TBL] [Abstract][Full Text] [Related]
25. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice. Weckbecker G; Raulf F; Bodmer D; Bruns C Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482 [TBL] [Abstract][Full Text] [Related]
26. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta. Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051 [TBL] [Abstract][Full Text] [Related]
27. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Colas B; Cambillau C; Buscail L; Zeggari M; Esteve JP; Lautre V; Thomas F; Vaysse N; Susini C Eur J Biochem; 1992 Aug; 207(3):1017-24. PubMed ID: 1499547 [TBL] [Abstract][Full Text] [Related]
29. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells. Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872 [TBL] [Abstract][Full Text] [Related]
30. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity. Florio T; Scorziello A; Thellung S; Salzano S; Berlingieri MT; Fusco A; Schettini G Endocrinology; 1997 Sep; 138(9):3756-63. PubMed ID: 9275062 [TBL] [Abstract][Full Text] [Related]
31. Effects of sodium stibogluconate on differentiation and proliferation of human myeloid leukemia cell lines in vitro. Pathak MK; Hu X; Yi T Leukemia; 2002 Nov; 16(11):2285-91. PubMed ID: 12399974 [TBL] [Abstract][Full Text] [Related]
33. The tumor-selective somatostatin analog, TT2-32 induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620. Vántus T; Csermely P; Teplán I; Kéri G Tumour Biol; 1995; 16(4):261-7. PubMed ID: 7604207 [TBL] [Abstract][Full Text] [Related]
34. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts. Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492 [TBL] [Abstract][Full Text] [Related]
35. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation. Nakamura K; Cambier JC J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943 [TBL] [Abstract][Full Text] [Related]
36. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells. Wang Y; Ripperger J; Fey GH; Samols D; Kordula T; Wetzler M; Van Etten RA; Baumann H Hepatology; 1999 Sep; 30(3):682-97. PubMed ID: 10462375 [TBL] [Abstract][Full Text] [Related]
37. SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma. Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; degli Uberti EC Endocrinology; 2005 Jun; 146(6):2692-8. PubMed ID: 15746253 [TBL] [Abstract][Full Text] [Related]
39. Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cells. Held-Feindt J; Forstreuter F; Pufe T; Mentlein R Brain Res Mol Brain Res; 2001 Feb; 87(1):12-21. PubMed ID: 11223155 [TBL] [Abstract][Full Text] [Related]
40. Characterization of a membrane tyrosine phosphatase in AR42J cells: regulation by somatostatin. Tahiri-Jouti N; Cambillau C; Viguerie N; Vidal C; Buscail L; Saint Laurent N; Vaysse N; Susini C Am J Physiol; 1992 Jun; 262(6 Pt 1):G1007-14. PubMed ID: 1352086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]